| http://www.w3.org/ns/prov#value | - This agreement is an example of our commitment to working with clinical companies in China and worldwide who want to develop and commercialize in vitro diagnostics based on next-generation sequencing, added Greg Heath, svp, IVD development at Illumina.
|
